×
About 5,955 results

ALLMedicine™ Candidiasis Center

Research & Reviews  1,741 results

Candida Chorioamnionitis in Mothers with Gestational Diabetes Mellitus: A Report of Two...
https://doi.org/10.3390/ijerph18147450
International Journal of Environmental Research and Publi... Shazniza Shaaya E, Halim SAA et. al.

Jul 24th, 2021 - Background:Candida chorioamnionitis is rarely encountered, even though vulvovaginal candidiasis incidence is about 15%. Interestingly, it has characteristic gross and histological findings on the umbilical cord that are not to be missed. Case Repo...

Aiming for a bull's-eye: Targeting antifungals to fungi with dectin-decorated liposomes.
https://doi.org/10.1371/journal.ppat.1009699
PLoS Pathogens; Meagher RB, Lewis ZA et. al.

Jul 22nd, 2021 - Globally, there are several million individuals with life-threatening invasive fungal diseases such as candidiasis, aspergillosis, cryptococcosis, Pneumocystis pneumonia (PCP), and mucormycosis. The mortality rate for these diseases generally exce...

Risks for Recurrent Vulvovaginal Candidiasis Caused by Non-Albicans Candida Versus Cand...
https://doi.org/10.1089/jwh.2020.8811
Journal of Women's Health (2002); Boyd Tressler A, Markwei M et. al.

Jul 22nd, 2021 - Background: Vulvovaginal candidiasis (VVC) is the second most common vulvovaginitis (VV). About 20% of women will experience recurrent infections in their lifetime with non-albicans Candida (NAC) species being one of the causative agents. Although...

Biallelic TRAF3IP2 variants causing chronic mucocutaneous candidiasis in a child harbor...
https://doi.org/10.1111/pai.13603
Pediatric Allergy and Immunology : Official Publication O... Blanco Lobo P, Lei WT et. al.

Jul 21st, 2021 - Inherited chronic mucocutaneous candidiasis (CMC) is often caused by inborn errors of immunity, impairing the response to, or the production of IL-17A and IL-17F. About half of the cases carry STAT1 gain-of-function (GOF) mutations. Only few patie...

HECT E3 Ubiquitin Ligase Nedd4 Is Required for Antifungal Innate Immunity.
https://doi.org/10.4049/jimmunol.2100083
Journal of Immunology (Baltimore, Md. : 1950); Nuro-Gyina PK, Tang N et. al.

Jul 20th, 2021 - Candida albicans is the most common cause of fungal infections in humans, and disseminated candidiasis has become one of the leading causes of hospital-acquired bloodstream infections with a high mortality rate. However, little is known about the ...

see more →

Guidelines  8 results

British HIV Association/British Infection Association guidelines on the management of o...
https://doi.org/10.1111/hiv.12806
HIV Medicine 7 References; Dockrell DH, O’Shea D et. al.

Nov 1st, 2019 - British HIV Association/British Infection Association guidelines on the management of opportunistic infection in people living with HIV: The clinical management of Candidiasis 2019.|2019|Dockrell DH,O’Shea D,Cartledge JD,Freedman AR,|diagnosis,dru...

Microbiological Laboratory Testing in the Diagnosis of Fungal Infections in Pulmonary a...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6727169
American Journal of Respiratory and Critical Care Medicine; Hage CA, Carmona EM et. al.

Aug 30th, 2019 - Background: Fungal infections are of increasing incidence and importance in immunocompromised and immunocompetent patients. Timely diagnosis relies on appropriate use of laboratory testing in susceptible patients.Methods: The relevant literature r...

ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormyc...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5394968
Haematologica Tissot F, Agrawal S et. al.

Dec 24th, 2016 - The European Conference on Infections in Leukemia (ECIL) provides recommendations for diagnostic strategies and prophylactic, pre-emptive or targeted therapy strategies for various types of infection in patients with hematologic malignancies or he...

Managing xerostomia and salivary gland hypofunction: executive summary of a report from...
https://doi.org/10.14219/jada.2014.44
Journal of the American Dental Association (1939); Plemons JM, Al-Hashimi I et. al.

Aug 1st, 2014 - Xerostomia, also known as "dry mouth," is a common but frequently overlooked condition that is typically associated with salivary gland hypofunction, which is the objective measurement of reduced salivary flow. Patients with dry mouth exhibit symp...

Intra-abdominal candidiasis: the guidelines-forgotten non-candidemic invasive candidiasis.
https://doi.org/10.1007/s00134-013-3134-2
Intensive Care Medicine; Montravers P, Dupont H et. al.

Oct 24th, 2013 - Intra-abdominal candidiasis: the guidelines-forgotten non-candidemic invasive candidiasis.|2013|Montravers P,Dupont H,Eggimann P,|therapeutic use,drug effects,drug therapy,microbiology,drug therapy,microbiology,

see more →

Drugs  375 results see all →

Clinicaltrials.gov  101 results

Study of Rezafungin Compared to Caspofungin in Subjects With Candidemia and/or Invasive Candidiasis
https://clinicaltrials.gov/ct2/show/NCT03667690

May 7th, 2020 - A Phase 3, multicenter, prospective, randomized, double-blind, efficacy and safety study of Rezafungin for Injection versus an active comparator regimen of caspofungin followed by optional oral fluconazole step-down therapy in subjects with candid...

Studies of Disorders With Increased Susceptibility to Fungal Infections
https://clinicaltrials.gov/ct2/show/NCT01222741

Apr 28th, 2020 - This study is designed for the evaluation, diagnosis, and long-term follow up of selected patients with primary immune deficiencies and other conditions associated with fungal, and more specifically with Candida spp. infections. The primary immune...

Open-Label Study to Evaluate the Efficacy and Safety of Oral Ibrexafungerp (SCY-078) in Patients With Candidiasis Caused by Candida Auris (CARES)
https://clinicaltrials.gov/ct2/show/NCT03363841

Dec 1st, 2019 - This is a multicenter, open-label, non-comparator, single-arm study to evaluate the efficacy, safety, tolerability and PK (for a subset of subjects) of oral SCY-078 in male and female subjects ≥18 years of age with a documented Candida auris infec...

CelAgace™ OraRinse Solution for Treatment of Candidiasis
https://clinicaltrials.gov/ct2/show/NCT03250923

Jul 24th, 2019 - CelAgace™ OraRinse (silver citrate complex and acemannan) Solution is being evaluated for safety and effectiveness as a potential treatment for candidiasis, a yeast infection, commonly known as thrush, which is associated with mouth sores. CelAgac...

Rwanda Vaginal Microbiota Restoration Study
https://clinicaltrials.gov/ct2/show/NCT02459665

Jul 15th, 2019 - This is a pilot study to prepare for larger clinical trials. Sixty-eight HIV-negative, non-pregnant, sexually active women aged 18-45 with bacterial vaginosis (BV, by modified Amsel criteria and/or Nugent score) and/or Trichomonas vaginalis (TV, o...

see more →

News  154 results

FDA Approves Ibrexafungerp for Vaginal Yeast Infection
https://www.medscape.com/viewarticle/952312

Jun 1st, 2021 - The US Food and Drug Administration (FDA) has approved ibrexafungerp tablets (Brexafemme) as a 1-day oral therapy for vaginal yeast infections, something 3 out of every 4 women encounter at least once in their life. Ibrexafungerp is the first drug...

Psoriasis Clearance Rates Higher With Bimekizumab vs Secukinumab
https://www.medscape.com/viewarticle/949914

Apr 23rd, 2021 - Secukinumab is the latest adult plaque psoriasis treatment to be bested by a newcomer, the interleukin 17A and 17F blocker bimekizumab. Rates of complete clearance were substantially higher with bimekizumab in a phase 3 trial with 743 patients wit...

Vulvovaginitis: A Commonsense Approach
https://www.medscape.com/viewarticle/944773

Feb 11th, 2021 - This transcript has been edited for clarity. Matthew F. Watto, MD: Welcome back to The Curbsiders. I'm Dr Matthew Watto, and I'm joined by my two good friends and board-certified internal medicine physicians, Dr Stuart Brigham and Dr Paul Williams...

Fast Five Quiz: Type 2 Diabetes Mellitus Presentation and Diagnosis
https://reference.medscape.com/viewarticle/922985_3

Jan 29th, 2020 - Polyuria, polydipsia, and polyphagia are clinical signs and symptoms of type 2 DM. Other symptoms of type 2 DM include blurred vision, lower extremity paresthesia, and repeated candidiasis (candida balanitis in male patients). Chest pain and short...

FDA Expands Use of Antifungal Micafungin (Mycamine) to Newborns
https://www.medscape.com/viewarticle/923628

Jan 8th, 2020 - The US Food and Drug Administration (FDA) has approved a supplemental New Drug Application (sNDA) for use of micafungin sodium (Mycamine, Astellas Pharma Inc) for injection in children younger than 4 months of age. The indication spans candidemia,...

see more →

Patient Education  3 results see all →